Elevance Health Inc. (ELV) Earnings History
Steady Earner25 years of earnings data (2001–2025) · Positive but moderate multi-year EPS trajectory
Loading earnings history...
Elevance Health Inc. (ELV) Earnings Overview
As of June 21, 2026, Elevance Health Inc. (ELV) reported trailing twelve-month net income of $5.24B, reflecting -2.2% year-over-year growth. The company earned $23.79 per diluted share over the past four quarters, with a net profit margin of 2.8%.
Looking at the long-term picture, ELV's 5-year EPS compound annual growth rate (CAGR) stands at +6.9%, showing solid earnings momentum. The company achieved its highest annual net income of $6.10B in fiscal 2021.
Elevance Health Inc. maintains positive profitability with a gross margin of 25.6%, operating margin of 4.1%, and net margin of 2.8%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including UNH ($12.04B net income, 2.7% margin), CVS ($2.93B net income, 0.4% margin), CI ($6.29B net income, 2.2% margin), ELV has outperformed on profitability metrics. Compare ELV vs UNH →
ELV Earnings vs Peers
Earnings metrics vs comparable public companies
ELV Historical Earnings Data (2001–2025)
25 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.66B | -5.3% | $8.11B | $25.12 | 2.8% | 4.1% |
| 2024 | $5.98B | -0.1% | $8.89B | $25.68 | 3.4% | 5.0% |
| 2023 | $5.99B | +1.6% | $8.74B | $25.22 | 3.5% | 5.1% |
| 2022 | $5.89B | -3.4% | $8.45B | $24.28 | 3.8% | 5.4% |
| 2021 | $6.10B | +33.5% | $8.95B | $24.73 | 4.4% | 6.5% |
| 2020 | $4.57B | -4.9% | $7.71B | $17.98 | 3.8% | 6.3% |
| 2019 | $4.81B | +28.2% | $6.73B | $18.47 | 4.6% | 6.5% |
| 2018 | $3.75B | -2.4% | $5.84B | $14.19 | 4.1% | 6.3% |
| 2017 | $3.84B | +55.6% | $4.99B | $14.35 | 4.3% | 5.5% |
| 2016 | $2.47B | -3.5% | $5.42B | $9.21 | 2.9% | 6.4% |
| 2015 | $2.56B | -0.4% | $5.36B | $9.38 | 3.2% | 6.8% |
| 2014 | $2.57B | -3.2% | $5.10B | $8.95 | 3.5% | 6.9% |
| 2013 | $2.65B | -0.0% | $4.69B | $8.74 | 3.7% | 6.6% |
| 2012 | $2.66B | +0.3% | $4.41B | $8.18 | 4.3% | 7.2% |
| 2011 | $2.65B | -8.3% | $4.48B | $7.25 | 4.4% | 7.4% |
| 2010 | $2.89B | -39.2% | $4.83B | $6.94 | 4.9% | 8.2% |
| 2009 | $4.75B | +90.5% | $4.94B | $9.88 | 7.7% | 8.0% |
| 2008 | $2.49B | -25.5% | $4.96B | $4.76 | 4.0% | 7.9% |
| 2007 | $3.35B | +8.1% | $5.95B | $5.56 | 5.4% | 9.7% |
| 2006 | $3.09B | +25.6% | $5.36B | $4.82 | 5.4% | 9.4% |
| 2005 | $2.46B | +156.6% | $4.13B | $3.94 | 5.5% | 9.2% |
| 2004 | $960M | +24.0% | $1.79B | $3.05 | 4.6% | 8.6% |
| 2003 | $774M | +41.0% | $1.20B | $2.73 | 4.6% | 7.2% |
| 2002 | $549M | +60.5% | $811M | $2.26 | 4.1% | 6.1% |
| 2001 | $342M | - | $525M | $1.65 | 3.3% | 5.0% |
Download Data
Export ELV earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into ELV consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
25+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ELV — Frequently Asked Questions
Quick answers to the most common questions about buying ELV stock.
What is ELV earnings per share (EPS)?
ELV trailing twelve-month (TTM) diluted EPS is $23.79, reflecting -2.2% year-over-year growth. The 5-year EPS CAGR is +6.9%. Complete EPS history from 2001 to 2025 is available in the table on this page.
What is Elevance Health Inc.'s net income?
Elevance Health Inc. (ELV) trailing twelve-month net income is $5.2B as of 2025. Earnings declined -2.2% year-over-year. Elevance Health Inc. has been profitable for 25 consecutive years.
Is ELV profitable?
Yes, ELV is profitable with a TTM net income of $5.2B and a net profit margin of +2.8%. Elevance Health Inc. has generated profits for 25 consecutive years.
What is ELV's earnings growth rate?
ELV compound annual EPS growth rates (CAGR): 1-Year: -2.2%, 3-Year: +1.1%, 5-Year: +6.9%, 10-Year: +10.4%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2001 to 2025.
What are ELV's profit margins?
Elevance Health Inc. net profit margin is +2.8%, operating margin is +4.1%, and gross margin is +25.6%. Below-average margins reflect competitive or cost pressures. Return on Equity is +13.3%.
Is ELV growing earnings?
ELV earnings growth is slowing. Current YoY EPS growth of -2.2% trails the 5-year CAGR of +6.9%. TTM net income is $5.2B.
What was ELV's best earnings year?
Elevance Health Inc.'s highest annual net income on record is $6.1B, achieved in fiscal year 2021. Earnings history on this page spans 2001 to 2025 and includes all annual and quarterly figures.
What were ELV's earnings last quarter?
ELV's most recent reported quarter was Q1 2026. Net income was $1.8B with diluted EPS of $8.00. For a full breakdown of all quarters, see the quarterly earnings table on this page.